CareDx, Inc. is a California-based company that develops molecular diagnostic tests. Its filings show it lobbies on Medicare and Medicaid issues, specifically seeking Medicare coverage and payment rules for molecular tests that detect solid organ transplant rejection and on implementation of a provision of the Protecting Access to Medicare Act of 2014. It has reported $120,000 in lobbying across three filings and hired Todd Strategy Group to represent it.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DANIEL M TODD
The latest disclosures for this client.
TODD STRATEGY GROUP
Q1TODD STRATEGY GROUP
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
TODD STRATEGY GROUP
KATHERINE FLEMING COTTON
TODD STRATEGY GROUP
NICHOLAS UEHLECKE
TODD STRATEGY GROUP
PAUL EDATTEL
TODD STRATEGY GROUP
TED LEHMAN
TODD STRATEGY GROUP
TODD STRATEGY GROUP
Q3TODD STRATEGY GROUP
RA